Mark Cherry has authored an important, intellectually challenging book. Not only does Cherry address important questions about the sale of organs, but he also raises thought-provoking, important moral questions about how we understand the body and moral authority in a secular society. The book raises important questions for transplantation ethics, bioethics, and political ethics. -- Kevin Wm. Wildes, SJ, President, Loyola University New Orleans Kidney for Sale by Owner is extremely important, especially at a time when the demand for organs is ever-increasing and the supply is not. Cherry addresses important issues in social and political philosophy, health care economics, public policy, and social justice. Policymakers and health care professionals involved in designing policy or position statements for professional organizations should look to this carefully argued and level-headed analysis of the arguments for and against the permissibility of selling organs. -- Ana Iltis, Assistant Professor, Center for Health Care Ethics, Saint Louis University, and Author of Institutional Integrity in Health Care Mark Cherry's book is the definitive treatment of the bioethical and business ethics questions that have been raised about a market in organs. It is must reading for anyone interested in these issues, and it will be the basis for all future discussion of this topic. -- Nicholas Capaldi, Legendre-Soule Distinguished Chair in Business Ethics, Loyola University New Orleans

If most Americans accept the notion that the market is the most efficient means to distribute resources, why should body parts be excluded? Each year thousands of people die waiting for organ transplants. Many of these deaths could have been prevented were it not for the almost universal moral hand-wringing over the concept of selling human organs. Kidney for Sale by Owner, now with a new preface, boldly deconstructs the roadblocks that are standing in the way of restoring health to thousands of people. Author and bioethicist Mark Cherry reasserts the case that health care could be improved and lives saved by introducing a regulated transplant organs market rather than by well-meant, but misguided, prohibitions.